Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Public ClinicalTrials.gov record NCT05401357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Multiple Dose, Parallel-group, Two-arm, Multicenter, Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® (Bimatoprost Ophthalmic Solution) 0.01% in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Study identification
- NCT ID
- NCT05401357
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Amneal Pharmaceuticals, LLC
- Industry
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Interventions
- Test - Bimatoprost 0.01% Ophthalmic Solution Drug
- Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2022
- Primary completion
- Nov 30, 2022
- Completion
- Nov 30, 2022
- Last update posted
- Aug 9, 2022
2022
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Eye Research Foundation Inc. | Newport Beach | California | 92663 | Recruiting |
| North Bay Eye Associates, Inc. | Petaluma | California | 94954 | Recruiting |
| Volusia Eye Associates | New Smyrna Beach | Florida | 32169 | Recruiting |
| Clayton Eye Clinical Research, LLC | Morrow | Georgia | 30260 | Recruiting |
| Coastal Research Associates, LLC | Roswell | Georgia | 30076 | Recruiting |
| Toyos Clinic | Nashville | Tennessee | 37215 | Recruiting |
| Keystone Research | Austin | Texas | 78731 | Not yet recruiting |
| Houston Eye Associates, North Loop | Houston | Texas | 77008 | Recruiting |
| Cheyenne Eye Clinic & Surgery Center | Cheyenne | Wyoming | 82001 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05401357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05401357 live on ClinicalTrials.gov.